Shopping Cart
- Remove All
- Your shopping cart is currently empty
Monensin is an antiprotozoal agent produced by Streptomyces cinnamonensis. It has an inhibitory effect on the Wnt/β-catenin signaling cascade. Monensin is a prospective anticancer drug for the therapy of neoplasia with deregulated Wnt signaling.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
50 mg | $1,023 | Backorder |
Description | Monensin is an antiprotozoal agent produced by Streptomyces cinnamonensis. It has an inhibitory effect on the Wnt/β-catenin signaling cascade. Monensin is a prospective anticancer drug for the therapy of neoplasia with deregulated Wnt signaling. |
Alias | Rumensin, Elancoban |
Molecular Weight | 670.87 |
Formula | C36H62O11 |
Cas No. | 17090-79-8 |
Relative Density. | 1.21 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: Soluble |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.